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Immunoglobulins and C3 were detected by immunofluorescence in the blood vessel walls of 
biopsies of clinically normal skin in patients with active necrotizing vasculitis. Of the 13 
patients studied, 9 had C3 and 6 of these had IgM or IgA in biopsies of lesions of vasculitis. In 
adjacent clinically normal skin, 7 patients had C3 and 3 of these also had IgM or IgA. These 
findings support the hypothesis that immunoglobulins and complement are present in vessels 
of some patients prior to chemotaxis of polymorphonuclear leukocytes and the resulting 
inflammatory purpuric lesions so characteristic of necrotizing vasculitis. 
Immunoglobulins and complement components 
may be found in the inflamed blood vessel walls of 
patients with a variety of forms of vasculitis [1 ]. 
Their presence has been used as presumptive 
evidence that antigen-antibody (immune) com-
plexes may be of pathogenetic significance in the 
lesions of vasculitis. Inherent in such an hypothesis 
is the assumption that, first, circulating antigen-
antibody complexes (with demonstrable immuno-
globulins) are deposited, followed by local activa-
tion of complement and subsequent blood vessel 
wall damage. To date, however, all of the above 
events have been noted simultaneously in the same 
vessels and no time-course has been established for 
various steps in development of the vasculitis. This 
study describes the presence of immunoglobulins 
and complement in vessels from clinically normal 
skin of some patients:j: with active vasculitis. · 
MATERIALS AND METHODS 
Patients. Of the 13 patients comprising this series, 11 
presented with cutaneous palpable purpura, 1 with 
hemorrhagic bullae, and 1 with urticaria . The purpuric 
lesions varied in size from 1 mm to 10 mm, and frequently 
evolved to a necrotic center (Fig. 1). 
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and their clinical abnormalities will not be described in 
this manuscript. 
Histopathologically, each lesion demonstrated endo-
thelial cell swelling with destruction of the vessel wall, 
polymorphonuclear leukocytic infiltration , nuclear dust 
(leukocytoclasis) , and hemorrhage (Fig. 2). Patients with 
these findings have been classified under such terms as 
necrotizing or leukocytoclastic vasculitis or allergic or 
hypersensitivity angiitis [2-4 ]. 
Immunofluorescence. Immunofluorescent studies were 
done on skin biopsies of lesions which had the same 
clinical appearance as and were within 1 to 5 em of those 
lesions biopsied for routine histology. In addition , clini-
cally normal skin within 1 to 5 em was also biopsied for 
immunofluorescence . Normal skin was not biopsied for 
routine histology but was biopsied for electron micros-
copy from which thick sections were prepared and 
examined by light microscopy. Both specimens for 
fluorescence were immediately snap frozen in liquid 
nitrogen and stored at -70°C until sectioned. Frozen 
sections were embedded in O.C.T. Compound (Ames 
Co.) , cut at 4 nm on an Ames cryostat, washed in 0.01 M 
phosphate-buffered (pH 7 .2) saline for 10 min to remove 
excess O.C.T. , and partially dried and overlaid with the 
respective fluorescein-labeled conjugate. Goat antihu-
man conjugates to lgG, lgM, lgA, C3, and fibrinogen were 
obtained from Hyland Laboratories, Los Angeles, Cali-
fornia, and their monospecificity was confirmed by im-
munoelectrophoresis and double immunodiffusion in 
agar gel. Properdin was isolated by the Zymogen method 
[5] and the antibody to properdin was prepared in a horse 
and conjugated with fluorescein at the University of 
Colorado Medical Center. Specificity of the horse anti-
properdin was confirmed by comparison with a rabbit 
antiproperdin donated by Dr. Irwin H. Lepow. The 
dilution of conjugate used was selected to give minimal 
background and maximum specific fluorescence on 
known positive control sections. The characteristics of 
the conjugates are given in Table I. After being washed in 
phosphate-buffered saline and mounted in glycerol, sec-
tions were examined with a Zeiss fluorescent microscope 
using a BG-12 primary filter and an 0-53 secondary filter. 
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The specificity of staining was determined by overlay-
ing a section with unlabeled goat antihuman C3 followed 
by fluorescein-labeled antihuman C3 to determine 
whether specific blocking would result in an abolition of 
staining. For those tissues which stained with anti-C3 by 
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direct immunofluorescence, further complement compo-
nent staining was performed using an indirect method. 
Tissue sections were first stained with unlabeled antihu-
man Clq, C4, C3, C5, or C3 proactivator (factor B). 
Antisera to Clq, C4, and C5 were prepared in goats in our 
laboratory using purified components. The anti-factor-B 
was from a rabbit and a gift of Dr. Otto Goetze at the 
Scripps Clinic, La Jolla, California . Controls, in addition 
to phosphate-buffered saline, included normal goat se-
rum. After washing, sections stained with goat antihu-
man Clq, C4 , C3, and C5 were stained with fluores-
FIG. 1. Characteristic lesions seen in patient 5. This 
man had numerous elevated purpuric lesions over his 
arms and trunk with confluence of individual lesions into 
large areas of necrosis on his legs. 
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cein-labeled rabbit antigoat lgG, while sections stained 
with rabbit anti-factor B were stained with fluorescein-
conjugated anti- rabbit lgG . The reason for using an 
indirect method for the complement components was the 
resulting increased sensitivity as well as the unavailabil-
ity of conjugated components. 
Complement. Fresh serum was frozen at - 70°C and 
total serum hemolytic complement was determined by 
the method of Mayer [6 ], while serum C3 was determined 
by radial immunodiffusion. 
Other tests. Serum antinuclear antibody was deter-
mined by fluorescent staining of mouse liver nuclei , 
rheumatoid factor by latex agglutination , and the pres-
ence of hepatitis B antigen by electroimmunodiffusion. 
Cryoprotein levels were determined by methods previ-
ously described [7 ]. 
Patient controls. Cutaneous vessels from biopsies of 
100 patients with a variety of skin diseases , including 
pemphigus, pemphigoid , erythema multiforme, and der-
matitis herpetiformis, were specifically examined using 
the same fluorescein conjugates as above. 
RESULTS 
Pertinent characteristics of the 13 patients are 
given in Table II . In all patients the antinuclear 
antibody, rheumatoid factor , and hepatitis B anti-
gen were negative. Six patients had abnormal 
amounts of serum cryoproteins but their presence 
did not correlate with the presence or absence of 
skin immunofluorescence. 
FIG. 2. Typical pathology seen in all patients in this study. This biopsy was from the lower leg of patient 4 and 
demonstrates a striking inflammatory reaction of the vessel walls. There is endothelial cell swelling, infiltration 
by polymorphonuclear leukocytes and leukocytoclasis (nuclear dust). The additional characteristic feature, 
hemorrhage, is not obvious in this view ( x 88). 
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The results of the cutaneous immunofluores-
cence are summarized in Table III. All slides were 
read by a single experienced observer without 
knowledge of the patient or site of the sample. No 
IgG was detectable in any biopsy from either 
normal or involved skin. Positive staining by one or 
more conjugates was detected in the lesions of 10 of 
the 13 patients. The intensity of fluorescence was 
graded arbitrarily from 1 to 4+, with 1+ being · 
weak but definite staining, and a 4+ indicating in-
tense fluorescence. When found, positive staining 
was always in vessels of the mid-to-upper dermis, 
sometimes only those in the papillae. Staining 
appeared to be within or immediately surrounding 
the vessel wall and was finely granular in character 
(Fig. 3). In biopsies from involved skin, 9 of the 13 
patients had vessel staining for C3, 4 for IgM, 
and 4 for IgA. No patient showed staining for IgG. 
Of the patients who were positive for C3, 4 were 
positive for C4, and 1 for Clq. The only patient 
whose vessels in a lesion had a bound immunoglob-
ulin, but no C3, was #7 with IgA. Six patients had 
evidence of renal involvement, 2 of these confirmed 
by renal biopsy. 
The most significant observation was positive 
TABLE I. Characteristics of conjugates 
Specific Fluore- Protein- Dilu-Protein see in bound antibody protein FITC tion cone. cone. for (mg/m[) (mg/m[) (molar cone. use 
ratio) (mg/m[) 
Anti-lgG 21.2 1.3 2.4 125 1:20 
Anti-lgA 21.9 2.4 2.5 132 1:10 
Anti-lgM 20.0 1.9 2.6 126 1:2 
Antifibrinogen 29.0 3.0 2.2 1:5 
Anti-C3 (B1c/B1a 12.3 2.0 3.4 102 1:20 
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staining in vessels from normal skin of 7 of the 
patients (Fig. 4). In some biopsies C3 staining in 
normal skin appeared considerably more intense 
than that from involved skin. In patient 9, staining 
for C3 and C4 in normal skin was positive while 
completely negative in a lesion. Fibrinogen seemed 
to be present in most vessels which showed positive 
staining by other conjugates. 
The specificity of the staining was confirmed by 
blocking C3 staining with unlabeled anti-C3. No 
vessel staining was demonstrated in any of the 
controls except patients with systemic lupus ery-
thematosus. Since no lesion stained with the 
conjugated anti-IgG, it was not felt that other 
negative controls were necessary to rule out non-
specific trapping of immunoglobulin and comple-
ment in the vessel wall. 
Examination of thick sections of normal skin 
prepared for electron microscopy and stained with 
toluidine blue did not reveal any abnormalities. 
DISCUSSION 
This study demonstrates the presence of immu-
noglobulins and complement in the walls of cu-
taneous blood vessels of normal skin in some 
patients with active necrotizing vasculitis. The 
implication is obvious; it suggests that this form of 
vasculitis may be mediated by circulating antigen-
antibody complexes, at least in some of the pa-
tients. We infer that the immunoglobulins repre-
sent antibodies bound to unidentified antigens. The 
fact that the vessels did not stain with all antisera 
used indicates that the immunoglobulins are spe-
cifically deposited in vessel walls. The only study 
similar to the present one was by Baart de la Paille-
Kuyper et al [8] in which they demonstrated IgA 
and fragments of C3 but no Clq in normal skin ves-
TABLE II. Vasculitis patient data 
Hemolytic Sedimenta-Cutaneous Hematuria Renal Serum C3 tion rate Cryoglobulin 
lesions Proteinuria (rbc/hpf) biopsy serum (mg/ml) (Westergren) (mg/100 ml) complement (mm/hr) 
Normal value Neg Neg 33-61 0.82-1.7 <15 <0.50 rpg/100 ml 
Patients 
1 Urticaria Neg Neg nd 41 1.6 44 Neg 
2 Palp purp Neg 5-20 nd 35 1.3 17 nd 
3 Palp purp 1+ 3-5 GN 38 1.6 20 0.48 
4 Palp purp 3+ 5-10 GN 55 1.4 17 9.5 
5 Palp purp nd 5-20 nd 33 1.6 42 nd 
6 Hemorrhagic Neg Neg nd 55 2.6 29 16.0 
bullae 
7 Palp purp Neg Neg nd 48 1.3 18 0.83 
8 Palp purp Neg Neg nd 42 1.4 25 2.8 
9 Palp purp 1+ Few nd 49 2.1 21 0.65 
10 Palp purp and Neg Neg nd 34 1.6 16 Neg 
urticaria 
11 Palp purp Neg Neg nd 54 1.8 9 ..0 Neg 
12 Palp purp Neg 100-150 nd 47 2.7 nd Neg 
13 Palp purp Neg Neg nd 45 2.1 28 6.9 
Abbreviations: palp purp = palpable purpura; nd = not done; Hpf = high power field; GN = glomerulonephritis. 
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TABLE Ill. Vasculitis immunofluorescence 
No. Site of biopsy Involved or IgA IgM Fibrin Clq C4 C3 C3pa Properdin 
uninvolved 
1 Abdomen lnv - - - nd nd - nd nd 
Abdomen Uninv - - - nd nd - nd nd 
2 Leg Inv - - - nd nd - nd nd 
Leg Uninv - - - nd nd - nd nd 
3 Leg Inv 1+ - 4+ - - 1+ - -
Leg Uninv 1+ - 3+ - 1+ 3+ - -
4 Leg Inv 1+ 1+ 3+ nd 3+ 3+ - nd 
Leg Uninv - - - - 2+ 1+ - -
5 Hand lnv - - 2+ - 1+ 1+ - -
Hand Uninv - - - nd nd - nd nd 
6 Leg lnv - 2+ - nd nd 1+ nd nd 
Leg Uninv - - - nd nd - nd nd 
7 Abdomen lnv 2+ - 2+ nd nd - nd nd 
Abdomen Uninv 3+ 1+ 1+ nd nd 2+ nd nd 
8 Foot lnv - - 4+ - - 2+ - nd 
Foot Uninv - - nd nd nd - nd nd 
9 Leg Inv - - nd nd nd - nd nd 
Leg Uninv - - 2+ - 2+ 2+ - -
10 Leg Inv - 1+ nd nd nd 4+ nd nd 
Leg Uninv - - nd nd nd 3+ nd nd 
11 Leg lnv - - nd - 1+ 2+ - -
Leg Uninv - - nd - - 2+ - -
12 Leg Inv 3+ - nd nd nd 1+ nd nd 
Leg Uninv nd nd nd nd nd nd nd nd 
13 Leg lnv - 1+ - 2+ 4+ 2+ - -
Leg Uninv - 1+ - 1+ 3+ 3+ - -
Generally, sections were not stained for complement components if C3 was negative. In some cases, insufficient 
tissue was available. 
Abbreviations: + == relative degree of positivity; - == negative; nd = not done; C3pa = C3 proactivator. 
FIG. 3. Finely granular fluorescence of C3 in biopsy of 
skin lesion of patient 4. The linear fluorescent material is 
the autofluo'rescence of elastic fibers ( x 70). 
sels of patients with Schonlein-Henoch purpura, 
suggesting to them activation of the alternate com-
plement pathway. 
It is not surprising that immunoglobulins and 
complement are not detected in lesions from some 
patients in this and other studies since Cochrane 
and Weigle [9] have shown experimentally that 
polymorphonuclear leukocytes will ingest and ca-
tabolize the antigen (and probably also the anti-
body) within 24 to 48 hr. Thus, it might reasonably 
FIG. 4. C3 fluorescence m the v~ssels of a biopsy from 
norma~ skin of patient 3 ( x 70). 
be expected that the highest yield of positive 
immunoflurescence will be found in early lesions. 
Even more important from the pathogenetic stand-
point is the finding of immunoglobulins or comple-
ment in vessels from clinically normal skin, but 
within the area where lesions have been forming. 
This implies that these vessels may soon be infil-
trated by leukocytes resulting in a fully developed, 
palpable and purpuric lesion. It is also not too 
surprising that not all vessels in normal skin of the 
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patients demonstrate deposition of immunoglobu-
lins since the clinical eruption is usually expressed 
as discrete lesions with intervening normal skin 
and does not involve all of a leg, for instance, dif-
fusely. Reasons why the vasculitis would select 
specific vessels and spare others are obscure, but 
the observation that vasculitis usually begins and 
is most pronounced on the lower extremities may 
well be related to hydrostatic pressure and possi-
bly "sludging." In rabbits the platelets presum-
ably necessary for release of vasoactive amines 
have been demonstrated to clump in areas of vas-
cular turbulence [10 ]. 
In 6 patients, complement components were 
detected and no immunoglobulin known to fix 
complement was observed. This is not surprising 
since C3 is the amplification step in the comple-
ment cascade and several hundred or thousand 
more C3 molecules may be bound in the vessel 
than Clq. Thus, since Clq is bound molecule for 
molecule to immunoglobulin, the amount of im-
munoglobulin bound may easily be below the 
detectable level of the fluorescent system used. In 
addition, C4 and C3, once activated, do not 
necessarily bind to the complex. These compo-
nents may combine with vessel walls themselves 
much as they do to red blood cells. This may 
further explain the absence of immunoglobulins in 
the presence of complement. 
The detection of Clq and C4 in some patients in 
the absence of detectable C3P A or properdin cer-
tainly indicates that the classical complement 
pathway is activated. The meaning of fibrin depo-
sition is not clear, but may simply be related to the 
marked inflammation and vessel wall destruction , 
as we have found it in other inflammatory der-
matoses such as erythema multiforme. 
It was considered that the serum of these pa-
tients might contain an antibody for an antigen in 
the vessel walls to account for the staining seen by 
direct immunofluorescence. To examine this possi-
bility , normal human skin was obtained from 4 
different individuals, and cryostat sections over-
lain with serum dilutions of neat, 1:5 and 1:10 from 
each vasculitis patient. After washing, each section 
was stained with fluorescein-conjugated antibody 
to either IgG, IgM, or C3. In no instance was 
staining of normal vessels or other structures 
found. 
The presence of immunoglobulins in the vessels 
of lesions of vasculitis has been appreciated for 
some years. Probably the first such demonstration 
was by Mellors and Ortega in 1956 [11] who found 
immunoglobulins in the arteries of a patient with 
periarteritis nodosa. String a and co-workers [12] 
studied 4 patients with a clinical disease similar to 
those in this report and found the vessels stained 
for IgG and C3 but not for IgM, albumin, or 
fibrinogen. Scott and Rowell [13] demonstrated 
globulin (type not specified) in the media or 
arterioles and the walls of capillaries in 3 patients 
having "necrotizing arteriolitis" but did not de-
scribe the clinical or pathologic characteristics in 
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any detail. Paronetto [14] confirmed these findings 
in a single patient with hypersensitivity angiitis. 
The largest immunofluorescent study of necrotiz-
ing vasculitis is that of 26 patients reported by 
Schroeter et al [1 ]. They found IgG most fre-
quently, but also IgM and C3, but no IgA. This is in 
striking contrast to our present study where no IgG 
was detectable in any patient. This might be 
explained if the IgG conjugate were weak or 
improperly made. However, the same conjugate 
regularly stained the dermal- epidermal zone of 
our lupus erythematosus biopsies used as controls 
for our conjugates. 
These fluorescent antibody studies clearly dem-
onstrating the presence of one or more immuno-
globulins and complement in the vessels of clini-
cally normal skin provide an additional observa-
tion to support the hypothesis that human leu-
kocytoclastic vasculitis is an immune-complex dis-
ease. 
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